Renaissance Technologies’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
Other funds holding SEEL
GJL
UIC
MCM
MWM
OMC
Renaissance Technologies's SEEL Position: Q4 2022 in Review
Renaissance Technologies sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2022, closing a stake of 52 shares — an estimated $206K sold.
Renaissance Technologies first reported a position in SEEL in Q1 2018 and held it in 15 quarters. The position peaked at $2.04M in Q2 2019. 63 funds tracked by Wall St. Rank hold SEEL as of Q4 2022.
- Renaissance Technologies reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
- Renaissance Technologies sold 52 Seelos Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $206K.
- Renaissance Technologies first reported a position in Seelos Therapeutics, Inc. Common Stock in Q1 2018 and held it in 15 quarters.
- Renaissance Technologies's Seelos Therapeutics, Inc. Common Stock position peaked at $2.04M in Q2 2019.
- 63 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2022.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.